Printer Friendly

COMPANY INFORMATION
Forbes Medi-Tech Inc. 200-750 Pender St W Vancouver, BC V6C 2T8 Tel: (604) 689-5899 Fax: (604) 689-7641 Contact Name David Goold Industry Pharmaceuticals		Key Executives Charles A. Butt, CEO David Goold, CFO Develops and commercializes nutraceutical products including functional foods and dietary supplements. The company has developed Reducol™, a sterol-based cholesterol-lowering ingredient.
FP ADVISOR COVERAGE Forbes Medi-Tech Inc. • FP Corporate Surveys • FP Directory of Directors • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF SEP 11/09 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta Nasdaq/FMTI $0.39 $0.78 $0.12 n.a. n.a. n.a. n.a. Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) n.a. n.a. $-0.14 June 30/09 n.a. n.a. n.a. $1,938
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08 12m Dec. 31/07 12m Dec. 31/06 $000s $000s $000s Operating revenue 7,844 8,904 6,116 Net income (7,652) (11,683) (10,844) Total assets 9,216 12,951 25,387 $ $ $ Earnings per share* (1.57) (2.40) (2.32) % % % Return on equity (120.66) (77.93) (76.80)   * Common
TRAILING 12-MONTH VALUES Periods ended: June 30/09 June 30/08 $000s $000s Operating revenue 4,864 9,581 Net income 136 (10,640) $ $ Earnings per share 0.12 (2.17)

COMPANY NEWS

Results for 'Forbes Medi-Tech Inc.' from past 30 days: No hits. (Links are to articles.)